Evaluating TnP as a Potential Therapeutic Agent for Retinopathy in Zebrafish Models

Area of Science:

• Ophthalmology and Neuroscience
• Drug Discovery and Development

Background:

• Retinal impairment leads to vision loss; current treatments are limited.
• TnP, a novel synthetic peptide, shows immunomodulatory potential in preclinical studies.
• Zebrafish models were used to study TnP's effects on retinopathy.

Purpose of the Study:

• To investigate the therapeutic effects of TnP on zebrafish models of retinopathy.
• To evaluate TnP's impact on diabetic retinopathy (DR)-like conditions induced by hypoxia and light damage.

Main Methods:

• Two zebrafish retinopathy models were established: cobalt chloride (CoCl2)-induced hypoxia and light-induced retinal damage (LIRD).
• TnP treatment was administered to the affected zebrafish.
• Outcomes were assessed using visual-motor response tests and histological examination of retinal morphology.

Main Results:

• Both CoCl2 exposure and LIRD impaired zebrafish swimming activity and movement.
• Distinct retinal morphological changes were observed in both injury models.
• TnP treatment did not reverse most injury effects but specifically restored the thickness of the inner plexiform layer (IPL).

Conclusions:

• TnP may promote neuronal plasticity, cell proliferation, and synaptic connectivity in the retina.
• TnP shows therapeutic promise for retinal and neurodegenerative disorders.
• Combined therapies may enhance TnP's efficacy.